Modified release formulations of a bupropion salt
US8932628B2 · kind B2 · utility
125Cited by
79References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 13, 2007 |
| Grant date | Jan 13, 2015 |
| Priority date | — |
| Expiry date | Aug 21, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.